TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 NOK)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
790
|
1,252
|
756 |
Financial expenses |
110
|
440
|
413 |
Earnings before taxes |
-115
|
97
|
67 |
EBITDA |
-16
|
537
|
469 |
Total assets |
14,601
|
14,903
|
14,683 |
Current assets |
768
|
1,152
|
907 |
Current liabilities |
257
|
386
|
263 |
Equity capital |
14,278
|
14,408
|
14,304 |
- share capital |
100
|
99
|
97 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
97.8%
|
96.7%
|
97.4% |
Turnover per employee |
790
|
1,252
|
756 |
Profit as a percentage of turnover |
-14.6%
|
7.7%
|
8.9% |
Return on assets (ROA) |
0.0%
|
3.6%
|
3.3% |
Current ratio |
298.8%
|
298.4%
|
344.9% |
Return on equity (ROE) |
-0.8%
|
0.7%
|
0.5% |
Change turnover |
-479
|
479
|
288 |
Change turnover % |
-38%
|
62%
|
61% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.